Paolo Ragonese

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 04, 2026

Accuracy of the central vein sign in diagnosis of multiple sclerosis: a systematic review and meta-analysis.

Accuracy of the central vein sign in diagnosis of multiple sclerosis: a systematic review and meta-analysis.

Journal: Journal of neurology

Published: December 02, 2025

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Journal: CNS drugs

Published: September 28, 2025

KIF5A and ALS: a clinical and genetic description of a case series and review of literature.

KIF5A and ALS: a clinical and genetic description of a case series and review of literature.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: September 01, 2025

Clinical and genetic findings of three patients with chorea-acanthocytosis.

Clinical and genetic findings of three patients with chorea-acanthocytosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 28, 2025

Sex differences in multiple sclerosis treatment with disease modifying drugs: a step towards gender neurology.

Sex differences in multiple sclerosis treatment with disease modifying drugs: a step towards gender neurology.

Journal: Multiple sclerosis and related disorders

Published: July 10, 2025

Organisational impact and patient management models for biomarker integration in multiple sclerosis care in Italy: the 0Tolerance project.

Organisational impact and patient management models for biomarker integration in multiple sclerosis care in Italy: the 0Tolerance project.

Journal: BMJ neurology open

Published: July 09, 2025

Risk of Cognitive Decline in Women with Parkinson's Disease Is Reduced by Early Age at Menarche.

Risk of Cognitive Decline in Women with Parkinson's Disease Is Reduced by Early Age at Menarche.

Journal: Neurology international

Published: May 30, 2025

Do exergames combined with physical exercise improve upper limb motor function in people with multiple sclerosis? Randomized clinical trial.

Do exergames combined with physical exercise improve upper limb motor function in people with multiple sclerosis? Randomized clinical trial.

Journal: Multiple sclerosis and related disorders

Published: May 12, 2025

Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patients.

Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patients.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: April 17, 2025

Shed Syndecans (1-3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson's Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel.

Shed Syndecans (1-3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson's Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel.

Journal: International journal of molecular sciences

Published: April 10, 2025

The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases.

The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: February 27, 2025

Showing 1-12 of 88

Last Updated: 09/26/2026